A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma

Bryostatin 1 is a naturally occurring macrocyclic lactone with promising antitumour and immunomodulatory function in preclinical and phase I clinical investigations. In this phase II study, 17 patients with progressive non-Hodgkin's lymphoma of indolent type (NHL), previously treated with chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackhall, F H, Ranson, M, Radford, J A, Hancock, B W, Soukop, M, McGown, A T, Robbins, A, Halbert, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363763/
https://www.ncbi.nlm.nih.gov/pubmed/11263437
http://dx.doi.org/10.1054/bjoc.2000.1624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363763/
https://www.ncbi.nlm.nih.gov/pubmed/11263437
http://dx.doi.org/10.1054/bjoc.2000.1624

Ejemplares similares